OCLN and cancer: That occludin immunostaining of epithelial tumors was often reduced as compared to their cells of origin is in agreement with various earlier reports suggesting a critical role of occludin downregulation for various cancer driving mechanisms such as reduction of cell adhesion and facilitation of cell dissociation, increased motility and proliferation, invasive tumor growth, and epithelial-mesenchymal transition.